Summary
The multiple pharmacological actions of unique synthetic compounds are a prerequisite for classifying a drug as highly efficacious, because the multiple pharmacological actions offer the possibility of treating various diseases like cancer. 1,3,4-Oxadiazoles are an important class of heterocyclic compounds with broad spectrum of biological activities. In this study we focused on the ability of these derivatives to induce apoptosis in cultured MCF-7 breast cancer cells. Treatment of MCF-7 cells with varying concentrations of the different derivatives resulted in dose and time dependent sequence of events marked by apoptosis, as shown by loss of cell viability, chromatin condensation, internucleosomal DNA fragmentation and sub G0 phase accumulation. Furthermore, apoptosis in MCF-7 cell was induced by upregulation of proto-oncoprotein Bax and activation of Caspase-3 activated DNase. Although the derivatives induced apoptosis was associated with Bax protein levels, negligible Bcl-2 reduction was observed. Analysis of the data suggests that the substituted oxadiazole derivatives exert antiproliferative action and growth inhibition on MCF-7 cells through apoptosis induction and that it may have anticancer properties valuable for application in drug products.
Similar content being viewed by others
References
Chang JC (1998) A review of breast cancer chemoprevention. Biomed Pharmacother 52:133–136
Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics. CA Cancer J Clin 47:5–27
Carolin KA, Pass HA (2000) Prevention of Breast cancer. Crit Rev Oncol Hematol 33:221–238
Khan MTH, Choudhari MI, Khan KM, Rani M, Atta-ur-Rahman (2005) Structure–activity relationships of tyrosinase inhibitory combinatorial library of 2, 5-disubstituted-1,3,4-oxadiazole analogues. Bioorg Med Chem 13:3385–3395
Holla BS, Gonsalves R, Shenoy S (2000) Synthesis and antibacterial studies of a new series of 1,2-bis(1,3, 4-oxadiazol-2-yl)ethanes and 1,2-bis(4-amino-1,2, 4-triazol-3-yl)ethanes. Eur J Med Chem 35:267–271
Sahin G, Palaska E, MelikeEkizoglu M, Ozalp M (2002) Synthesis and antimicrobial activity of some 1,3,4-oxadiazole derivatives. II Farmaco 57:539–545
Macaev F, Rusu G, Pogrebnoi S, Gudima A, Stingaci E, Vlad L, Shvets N, Kandemirli F, Dimoglo A, Reynolds R (2005) Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities. Bioorg Med Chem 13:4842–4850
Zou X, Zhang Z, ** G (2002) Synthesis and biological activity of 1,3,4- oxadiazole-substituted pyridazinones. J Chem Res Synopses 2002:228–230
Zou XJ, Lai LH, ** GY, Zhang ZX (2002) Synthesis, fungicidal activity, and 3D-QSAR of pyridazinone-substituted 1,3,4-oxadiazoles and 1,3,4-thiadiazoles. J Agri Food Chem 50:3757–3760
Burbuliene MM, Jakubkiene V, Mekuskiene G, Udrenaite E, Smicius R, Vainilavicius P (2004) Synthesis and anti-inflammatory activity of derivatives of 5-[(2- disubstitutedamino-6-methyl-pyrimidin-4-yl)-sulfanylmethyl]-3H-1,3,4-oxadiazole-2-thiones. II Farmaco 59:747–767
Palaska E, Sahin G, Kelicen P, Durlu NT, Altinok G (2002) Synthesis and antimicrobial activity of some 1,3,4-oxadiazole derivatives. Farmaco 57:101–107
Amir M, Shikha K (2004) Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2,6-dichloroanilino) phenyl]acetic acid derivatives. Eur J Med Chem 39:535–545
Zarghi A, Sayyed A, Tabatabai M, Faizi A, Ahadian P, Navabi V, Zanganeh A, Shafiee A (2005) Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles. Bioorg Med Chem Lett 15:1863–1865
Almasirad A, Sayyed A, Tabatabai M, Faizi A, Kebriaeezadeh N, Mehrabi A, Dalvandie A, Shafiee A (2004) Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles. Bioorg Med Chem Lett 14:6057–6059
Zheng X, Li Z, Wang Y, Chen W, Huang O, Liu C, Song C (2003) Syntheses and insecticidal activities of novel 2,5-disubstituted 1,3,4-oxadiazoles. J Fluor Chem 123:163–169
Meyer HR (1976) Chem Abstr 85 125807 [Swiss Patent, (1976), 577, 536]
Hill J, in: Katritzky AR (Ed.) (1994) Comprehensive Heterocyclic Chemistry Pergamon Press, Oxford 427(4)
Bold RJ, Termuhlen PM, McConkey DJ (1997) Apoptosis, cancer and cancer therapy. Surg Oncol 6:133–142
Kamesaki H (1998) Mechanisms involved in chemotherapy-induces apoptosis and their implications in cancer chemotherapy. Int J Hematol 68:29–43
Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462
Kroemer G, Petit P, Zamzami N, Vassiere JL, Mignotte B (1995) The biochemistry of programmed cell death. Fed Am Soc Exp Biol J 9:1277–1287
Wyllie AH, Kerr JF, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251–306
Wyllie AH (1987) Apoptosis: cell death in tissue regulation. J Pathol 153:313–316
Bortner CD, Oldenburg NBE, Cidlowsky JA (1995) The role of DNA fragmentation in apoptosis. Trends Cell Biol 5:21–26
Earnshaw WC (1995) nuclear changes in apoptosis. Curr Opin Cell Biol 7:337–343
Levenson AS, Jordan CV (1997) MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res 57:3071–3078
Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinodou D, Ali S, Nakshatri H (2001) Phosphatidyl-inositol/3-kinase/Akt-mediated activation of estrogen receptor α: a new model for anti-estrogen receptor resistance. J Biol Chem 276:9817–9824
Spencer CM, Faulds D (1994) Paclitaxel. A review of its pharmocodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 48:794–847
Gaonkar SL, Rai KML, Prabhuswamy B (2006) Synthesis and antimicrobial studies of a new series of 2-{4-[2-(5-ethylpyridin-2-yl) ethoxy] phenyl}-5-substituted-1,3,4- oxadiazoles. Eur J Med Chem 41:841–846
Giridharan P, Somasundaram ST, Perumal K, Vishwakarma NP, Velmurugan R (2002) Novel substituted methylenedioxylignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis. Br J Cancer 87:98–105
Srinivas G, Anto RJ, Srinivas P, Lakshmi SV, Senan PV, Karunagaran D (2003) Emodin induces apoptosis of human cervical cancer cells through Poly (ADP-Ribose) polymerase cleavage and activation of caspase-9. Eur J Pharmacol 473:117–125
Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309–1312
Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281:1322–1326
Rao L, White E (1997) Bcl-2 and ICE family of apoptotic regulators: making a connection. Curr Opin Genet Dev 7:52–58
Jacobson MD, Raff MC (1995) Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814–816
Jacobson MD, Burne JF, Raff MC (1994) Mechanisms of programmed cell death and Bcl-2 protection. Biochem Soc Trans 22:600–602
Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619
Widlak P (2000) The DFF-40/CAD endonuclease and its role in apoptosis. Acta Biochim Pol 47(4):1037–1044
Eamshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspase: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383–424
Thornberry N, lazebnik Y (1998) Caspases: enemies within. Science 281:1312–1316
Esposti MD (2002) The roles of Bid. Apoptosis 7:433–440
Korsmeyer SJ, Wei MC, Saito M, Wieler S, Oh J, Schlesinger PH (2000) Proapoptotic cascade activates Bid, which oligomerized BAK or Bax into pores that result in the release of cytochrome C. Cell Death Differ 7:1166–1173
Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (1998) Bid, a Bcl-2 interacting protein, mediates cytochrome C release from mitochondria in response to activation of cell death receptors. Cell 94:481–490
Acknowledgements
The author (AK) thanks University Grant Commission (UGC), New Delhi, and the author (SSD) thanks Lady Tata Memorial Trust, Mumbai, India, for the financial support. The authors express their sincere gratitude to University of Mysore, Mysore, India for the laboratory facility.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, A., D’Souza, S.S., Gaonkar, S.L. et al. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by a new series of substituted-1,3,4-oxadiazole derivatives. Invest New Drugs 26, 425–435 (2008). https://doi.org/10.1007/s10637-008-9116-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-008-9116-5